安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688075 安旭生物

已收盘 09-20 15:00:00

{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":31.56,"timestamp":1726815600000,"preClose":31.3,"halted":0,"volume":227819,"delay":0,"floatShares":31770800,"shares":127000000,"eps":0.709,"marketStatus":"已收盘","marketStatusCode":5,"change":0.26,"latestTime":"09-20 15:00:00","open":31.31,"high":31.62,"low":31.15,"amount":7137900,"amplitude":0.015,"askPrice":31.56,"askSize":10,"bidPrice":31.53,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.709,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727055000000},"adr":0,"adjPreClose":31.3,"symbolType":"stock_kcb","openAndCloseTimeList":[[1726795800000,1726803000000],[1726808400000,1726815600000]],"highLimit":34.43,"lowLimit":28.17,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":127082805,"pbRate":0.78,"roa":"--","roe":"2.23%","epsLYR":1.11,"committee":-0.228916,"marketValue":4011000000,"floatMarketCap":1003000000,"peRate":44.5134,"changeRate":0.0083,"turnoverRate":0.0072,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-09-23。","afterMarket":{"amount":0,"volume":0,"close":31.56,"buyVolume":0,"sellVolume":0,"time":1726817637154,"indexStatus":"已收盘 09-20 15:30:00","preClose":31.3}},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2468482603","title":"安旭生物获得外观设计专利授权：“宠物生化检测盘片”","url":"https://stock-news.laohu8.com/highlight/detail?id=2468482603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468482603?lang=zh_cn&edition=full","pubTime":"2024-09-17 02:16","pubTimestamp":1726510560,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权，专利名为“宠物生化检测盘片”，专利申请号为CN202330810608.0，授权日为2024年9月17日。今年以来安旭生物新获得专利授权14个，较去年同期减少了30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091700000560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2467430782","title":"安旭生物获得实用新型专利授权：“一次性末梢采血取血的装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2467430782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467430782?lang=zh_cn&edition=full","pubTime":"2024-09-13 02:15","pubTimestamp":1726164912,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项实用新型专利授权，专利名为“一次性末梢采血取血的装置”，专利申请号为CN202322870099.8，授权日为2024年9月13日。今年以来安旭生物新获得专利授权13个，较去年同期减少了31.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300001954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2466157600","title":"安旭生物：\n公司业绩主要系汇兑收益变动所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2466157600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466157600?lang=zh_cn&edition=full","pubTime":"2024-09-09 18:04","pubTimestamp":1725876271,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物09月09日在投资者关系平台上答复投资者关心的问题。公司业绩主要系汇兑收益变动所致，感谢您的关注！安旭生物董秘：尊敬的投资者，公司的合作方情况请查询公开信息，该产业基金已完成注册及登记，请查阅公司2022-032临时公告，公司的实际出资需根据项目的实际推进缴纳，感谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900025134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2463124070","title":"安旭生物8月28日获融资净买入47万元 环比增加1258.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463124070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463124070?lang=zh_cn&edition=full","pubTime":"2024-08-30 10:00","pubTimestamp":1724983218,"startTime":"0","endTime":"0","summary":"8月28日，安旭生物获融资净买入47万元，环比上一交易日增加1258.34%。其中，融资买入133万元，融资偿还85万元。A股市场共有3358股获融资净买入，安旭生物净买入额排名第872。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408301004429f673d50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408301004429f673d50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2463959212","title":"图解安旭生物中报：第二季度单季净利润同比减61.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463959212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463959212?lang=zh_cn&edition=full","pubTime":"2024-08-30 02:07","pubTimestamp":1724954862,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物2024年中报显示，公司主营收入2.48亿元，同比上升21.42%；归母净利润1.15亿元，同比下降30.85%；扣非净利润1888.5万元，同比下降80.95%；其中2024年第二季度，公司单季度主营收入1.19亿元，同比上升43.25%；单季度归母净利润4512.82万元，同比下降61.08%；单季度扣非净利润-74.47万元，同比下降100.82%；负债率10.79%，投资收益7482.5万元，财务费用-1042.26万元，毛利率40.82%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000003194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"gpt_icon":0},{"id":"2463660268","title":"安旭生物(688075.SH)发布上半年业绩，净利润1.15亿元，同比下降30.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463660268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463660268?lang=zh_cn&edition=full","pubTime":"2024-08-29 22:52","pubTimestamp":1724943122,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安旭生物(688075.SH)发布2024年半年度报告，公司营业收入2.48亿元，同比增长21.42%;归属于上市公司股东的净利润1.15亿元，同比下降30.85%;归属于上市公司股东的扣除非经常性损益的净利润1888.5万元，同比下降80.95%;基本每股收益0.91元/股。拟向全体股东每10股派发现金红利4元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1175814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075"],"gpt_icon":0},{"id":"2463025911","title":"安旭生物最新公告：2024年上半年净利润同比下降30.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463025911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463025911?lang=zh_cn&edition=full","pubTime":"2024-08-29 21:30","pubTimestamp":1724938257,"startTime":"0","endTime":"0","summary":"安旭生物发布2024年半年度报告，报告期内，公司实现营业收入约2.48亿元，同比增长21.42%；归属于上市公司股东的净利润约1.15亿元，同比下降30.85%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900042432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"gpt_icon":0},{"id":"2460038218","title":"安旭生物：\n请查阅公司公开信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2460038218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460038218?lang=zh_cn&edition=full","pubTime":"2024-08-19 20:00","pubTimestamp":1724068849,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物08月19日在投资者关系平台上答复投资者关心的问题。国外禽流感疫情严重，贵司是否有研发可以检测H5病毒的试剂盒？本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900028792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2460764652","title":"安旭生物（688075）8月16日主力资金净买入145.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460764652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460764652?lang=zh_cn&edition=full","pubTime":"2024-08-17 08:11","pubTimestamp":1723853496,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月16日收盘，安旭生物报收于35.69元，上涨4.17%，换手率4.22%，成交量1.34万手，成交额4729.79万元。近5日资金流向一览见下表：安旭生物融资融券信息显示，融资方面，当日融资买入168.73万元，融资偿还320.08万元，融资净偿还151.34万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700012805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2459418141","title":"世卫组织拉响猴痘疫情最高级别警报 相关医疗保健股飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2459418141","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459418141?lang=zh_cn&edition=full","pubTime":"2024-08-15 14:55","pubTimestamp":1723704929,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，世界卫生组织宣布正在非洲迅速蔓延的猴痘变异株疫情构成“国际关注的突发公共卫生事件”，这也是《国际卫生条例》框架下的最高级别全球疫情警报。受该消息影响，相关疫苗和和医疗产品生产商的股价上涨。世界卫生组织上一次将猴痘称为国际关注的突发公共卫生事件是在2022年5月，当时全球暴发了较温和的猴痘疫情。一年后，当世界卫生组织降低警报级别时，非洲的病例仍在继续增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688317","BK0168","BK0046","BK0122","BK0188","BK0028","002030","BK0239","BK0159","688075","BK0042"],"gpt_icon":0},{"id":"2459596744","title":"安旭生物（688075）8月14日主力资金净卖出200.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459596744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459596744?lang=zh_cn&edition=full","pubTime":"2024-08-15 08:20","pubTimestamp":1723681215,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月14日收盘，安旭生物报收于33.8元，下跌3.15%，换手率1.69%，成交量5354.0手，成交额1816.52万元。近5日资金流向一览见下表：安旭生物融资融券信息显示，融资方面，当日融资买入87.35万元，融资偿还56.45万元，融资净买入30.9万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500012792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2459387081","title":"安旭生物获得外观设计专利授权：“核酸检测仪（恒温）”","url":"https://stock-news.laohu8.com/highlight/detail?id=2459387081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459387081?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:20","pubTimestamp":1723573228,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权，专利名为“核酸检测仪（恒温）”，专利申请号为CN202330731075.7，授权日为2024年7月30日。今年以来安旭生物新获得专利授权9个，较去年同期减少了50%。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.05亿元，同比减68.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400003393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2457879033","title":"安旭生物8月6日获融资净买入22万元 环比增加244.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457879033","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457879033?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:00","pubTimestamp":1723082420,"startTime":"0","endTime":"0","summary":"8月6日，安旭生物获融资净买入22万元，环比上一交易日增加244.73%。其中，融资买入103万元，融资偿还80万元。融券方面，融券卖出0.00万股，当前融券余量为0.34万股。A股市场共有3354股获融资净买入，安旭生物净买入额排名第1356。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808100248958748fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808100248958748fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2456148791","title":"安旭生物7月30日获融资净买入53万元 环比增加798.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456148791","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456148791?lang=zh_cn&edition=full","pubTime":"2024-08-01 10:00","pubTimestamp":1722477621,"startTime":"0","endTime":"0","summary":"7月30日，安旭生物获融资净买入53万元，环比上一交易日增加798.17%。其中，融资买入98万元，融资偿还44万元。融券方面，融券卖出0.07万股，当前融券余量为0.66万股。A股市场共有3350股获融资净买入，安旭生物净买入额排名第1090。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011004099572fac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011004099572fac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2455694294","title":"安旭生物获得外观设计专利授权：“核酸检测仪（恒温）”","url":"https://stock-news.laohu8.com/highlight/detail?id=2455694294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455694294?lang=zh_cn&edition=full","pubTime":"2024-07-30 02:12","pubTimestamp":1722276736,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示安旭生物新获得一项外观设计专利授权，专利名为“核酸检测仪（恒温）”，专利申请号为CN202330731075.7，授权日为2024年7月30日。今年以来安旭生物新获得专利授权9个，较去年同期减少了47.06%。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.05亿元，同比减68.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000001956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2454374903","title":"安旭生物（688075）7月25日主力资金净卖出158.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454374903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454374903?lang=zh_cn&edition=full","pubTime":"2024-07-26 08:22","pubTimestamp":1721953367,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月25日收盘，安旭生物报收于33.13元，下跌1.98%，换手率1.63%，成交量5163.0手，成交额1723.02万元。近5日资金流向一览见下表：安旭生物融资融券信息显示，融资方面，当日融资买入136.55万元，融资偿还555.66万元，融资净偿还419.11万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600012682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2452059401","title":"安旭生物：\n请参见公司披露的公开信息中关于公司主营产品分类","url":"https://stock-news.laohu8.com/highlight/detail?id=2452059401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452059401?lang=zh_cn&edition=full","pubTime":"2024-07-18 18:02","pubTimestamp":1721296934,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物(688075)07月18日在投资者关系平台上答复投资者关心的问题。投资者：尊敬的董秘您好！请问贵司是否可以对食品进行检测？安旭生物董秘：尊敬的投资者，您好！请参见公司披露的公开信息中关于公司主营产品分类。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800037536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2451984185","title":"安旭生物（688075）7月12日主力资金净买入780.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451984185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451984185?lang=zh_cn&edition=full","pubTime":"2024-07-13 08:12","pubTimestamp":1720829569,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月12日收盘，安旭生物报收于36.43元，上涨3.94%，换手率4.51%，成交量1.43万手，成交额5226.59万元。近5日资金流向一览见下表：安旭生物融资融券信息显示，融资方面，当日融资买入440.9万元，融资偿还674.37万元，融资净偿还233.46万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071300012309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2450897465","title":"安旭生物：杭金投、荣泽石投资等多家机构于7月12日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2450897465","media":"证星公司调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450897465?lang=zh_cn&edition=full","pubTime":"2024-07-12 19:52","pubTimestamp":1720785120,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年7月12日安旭生物发布公告称杭金投、荣泽石投资、国泰君安、久盈资产、台州城投、司渝资产、中喜投资、浙商银行、玖龙资产、兴邦达于2024年7月12日调研我司。目前我们正在试图通过资源整合、技术合作或者投资并购等方式拓展公司医学相关领域的版图，逐步实现安旭生物医疗大健康产业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121953339f3b90b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121953339f3b90b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2450114347","title":"新冠抗原检测概念盘中拉升，安旭生物涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450114347","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450114347?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:54","pubTimestamp":1720749241,"startTime":"0","endTime":"0","summary":"07月12日，新冠抗原检测概念盘中拉升，截至09点53分，新冠抗原检测概念整体指数上涨0.50%，报701.680点。从个股上来看，该概念的成分股中，安旭生物涨5.28%，塞力医疗、东方海洋、百普赛斯涨幅居前。从资金上来看，截止发稿，新冠抗原检测概念主力净流入为-1952.50万，其中润达医疗受到资金热捧，主力净流入460.68万；拉长时间线来看，该板块近20日主力资金净流入-13.48亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095401941f6789&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095401941f6789&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-11-18","address":"浙江省杭州市余杭区莫干山路1418-50号4幢3层(上城科技工业基地)","stockEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":-0.0693},{"period":"3month","weight":-0.0767},{"period":"6month","weight":-0.1058},{"period":"1year","weight":-0.2164},{"period":"ytd","weight":-0.2069}],"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","perCapita":"4638股","boardName":"医药制造业","registeredCapital":"12708万元","compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":-0.0419},{"period":"3month","weight":-0.0872},{"period":"6month","weight":-0.1021},{"period":"1year","weight":-0.1128},{"period":"ytd","weight":-0.08}],"survey":"　　杭州安旭生物科技股份有限公司专注于POCT试剂及仪器的研发、生产与销售。公司主要产品为POCT试剂及仪器。公司拥有抗原抗体自主研发生产的生物原料技术平台，以及成熟的免疫层析及干式生化诊断技术平台，发展形成了覆盖毒品检测、传染病检测、慢性病检测、妊娠检测、肿瘤检测、心肌检测、生化检测、过敏原检测八大领域的POCT试剂，产品远销美国、德国、英国、加拿大、俄罗斯、墨西哥、泰国、印尼及波兰等150多个国家，已成为国内少数几家在POCT国际市场能够与跨国体外诊断行业巨头竞争的中国体外诊断产品供应商之一。","serverTime":1726880469645,"listedPrice":78.28,"stockholders":"6849人(较上一季度减少0.98%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.27.0","shortVersion":"4.27.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}